AKT1 and breast cancer: A study in breast cancer cells showed that MET decreases Akt activation and promotes apoptotic death [4], while in SH-SY5Y neuroblastoma cells, phosphorylated Akt was increased by MET treatment, which is associated with neuronal differentiation [5].